Human Papillomavirus Vaccine Impact Monitoring Project Across CT (HPV-IMPACT) |
|
Purpose
This project aims to monitor the impact of human papillomavirus (HPV) vaccine on cervical cancer precursors and HPV types associated with those precursors. |
Goals & Objectives
- Monitor HPV vaccine impact on cervical cancer precursors, cervical intraepithelial neoplasia (CIN) grade 2 and 3 and adenocarcinoma in situ (AIS).
- Monitor HPV vaccine impact on HPV types associated with CIN 2/3 and AIS lesions.
- Improve public health practice through local population-based surveillance of HPV-related cervical cancer precursors.
|
Activities
- Statewide passive monitoring of CIN2/3 and AIS diagnoses from pathology laboratories
- Population-based active surveillance for CIN 2/3 and AIS in New Haven county
- enhanced data collection to determine HPV vaccination status
- specimen collection to determine HPV type associated with CIN2/3 and AIS diagnoses
Back to Top |
| |
Related Links
Yale Emerging Infections Program Selected to Monitor Impact of HPV Vaccine
CT DPH makes CIN2/3 and AIS reportable conditions
Back to Top
|
Project Contact Person
Pam Julian, MPH
Project Coordinator
Yale Emerging Infections Program
One Church Street, 7th floor
New Haven, CT 06510
(203) 764-9705
Back to Top
|
